Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
YUMANITY THERAPEUTICS, INC.
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization
Over Five Years Ago
Previous Name(s)
- PROTEOSTASIS THERAPEUTICS, INC.
- PROTEOSTASIS THERAPEUTICS INC
Item 2 Issuer Principal Place of Business and Contact Information
40 GUEST STREET
SUITE 4410
BOSTON, MA 02135
Phone Number:
subscription required
Item 3. Related Persons
Name
RICHARD PETERS
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
N. ANTHONY COLES
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
PAULASH MOHSEN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
BRIGITTE ROBERTSON
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
PATRICIA L. ALLEN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
DAVID ARKOWITZ
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
KIM C. DRAPKIN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
RICHARD A. HEYMAN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JEFFERY W. KELLY
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
CECIL B. PICKETT
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
LYNNE ZYDOWSKY
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
OTHER HEALTH CARE
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
12/22/2020
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 12. Sales Compensation
Recipient
JEFFERIES LLC
Recipient CRD Number
2347
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
520 MADISON AVENUE, 2ND FLOOR
NEW YORK, NY 10022
States of Solicitation
- CA
- CO
- CT
- MD
- MA
- NY
- OR
- PA
- TX
Item 13. Offering and Sales Amounts
Total Offering Amount
33599895
Total Amount Sold
33599895
Total Remaining to be Sold
0
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
16
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
1716000.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
YUMANITY THERAPEUTICS, INC.
Issuer Signature
/S/PAULASH MOHSEN
Signer Name
PAULASH MOHSEN
Signer Title
CHIEF BUSINESS OFFICER
Signature Date
01/06/2021